http://orcid.org/0000-0001-5030-7930
Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Daniela Amicizia, Matteo Astengo, Chiara Paganino, Maria Francesca Piazza, Camilla Sticchi, Andrea Orsi, Federica Varlese, Tianyan Hu, Tanaz Petigara, Francesca Senese, Gian Marco Prandi, Giancarlo Icardi & Filippo Ansaldi. (2022) Economic burden of pneumococcal disease in children in Liguria, Italy. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Josiah Ryman, Jessica Weaver, Ka Lai Yee & Jeffrey R. Sachs. (2022) Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children. Expert Review of Vaccines 21:10, pages 1515-1521.
Read now
Read now
Randall Severance, Howard Schwartz, Ron Dagan, Laurie Connor, Jianing Li, Alison Pedley, Jonathan Hartzel, Tina M. Sterling, Katrina M. Nolan, Gretchen M. Tamms, Luwy K. Musey & Ulrike K. Buchwald. (2022) Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU). Human Vaccines & Immunotherapeutics 18:1, pages 1-14.
Read now
Read now
Gregory Tyrrell, Cerina Lee & Dean Eurich. (2021) Is there a need for pneumococcal vaccination programs for the homeless to prevent invasive pneumococcal disease?. Expert Review of Vaccines 20:9, pages 1113-1121.
Read now
Read now
Johnna Perdrizet, Carlos Felipe S. Santana, Thais Senna, Rodrigo Fernandes Alexandre, Rodrigo Sini de Almeida, Julia Spinardi & Matt Wasserman. (2021) Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. Human Vaccines & Immunotherapeutics 17:4, pages 1162-1172.
Read now
Read now
Tianyan Hu, Thomas Weiss, Goran Bencina, Kwame Owusu-Edusei & Tanaz Petigara. (2021) Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries. Journal of Medical Economics 24:1, pages 1098-1107.
Read now
Read now
Tianyan Hu, Thomas Weiss, Kwame Owusu-Edusei & Tanaz Petigara. (2020) Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States. Journal of Medical Economics 23:12, pages 1653-1660.
Read now
Read now
Nicolas Lecrenier, Alen Marijam, Jan Olbrecht, Lamine Soumahoro, Javier Nieto Guevara & Bruce Mungall. (2020) Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (Synflorix) in children. Expert Review of Vaccines 19:3, pages 247-265.
Read now
Read now
T.R. Converso, L. Assoni, G.O. André, M. Darrieux & L.C.C. Leite. (2020) The long search for a serotype independent pneumococcal vaccine. Expert Review of Vaccines 19:1, pages 57-70.
Read now
Read now
Viviane Maimoni Gonçalves, Kan Kaneko, Carla Solórzano, Ronan MacLoughlin, Imran Saleem & Eliane Namie Miyaji. (2019) Progress in mucosal immunization for protection against pneumococcal pneumonia. Expert Review of Vaccines 18:8, pages 781-792.
Read now
Read now
Articles from other publishers (41)
Marija Barbateskovic, Sarah Louise Klingenberg, Sara Russo Krauss, Dezhao Kong, Zhangtong Wu, Sesilje B. Petersen, Mette Kenfelt & Christian Gluud. (2023) Concentrations, Number of Doses, and Formulations of Aluminium Adjuvants in Vaccines: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials. Vaccines 11:12, pages 1763.
Crossref
Crossref
Timothy J. Chapman, Shrita M. Patel, Sheryl A. Flores, Shengjie Xu, Robert Lupinacci, Yaru Shi, Tulin Shekar, Kristen Feemster, Jumi Yi, Gretchen Tamms, Janusz KaminskiKara Bickham, Luwy Musey, Ulrike K. Buchwald & Natalie Banniettis. (2023) Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies. Pediatric Infectious Disease Journal 42:11, pages 1021-1028.
Crossref
Crossref
Cristiano E. Rodrigues Reis, Thais Suzane Milessi, Márcio Daniel Nicodemos Ramos, Akhilesh Kumar Singh, Gunda Mohanakrishna, Tejraj M. Aminabhavi, P. Senthil Kumar & Anuj K. Chandel. (2023) Lignocellulosic biomass-based glycoconjugates for diverse biotechnological applications. Biotechnology Advances 68, pages 108209.
Crossref
Crossref
Isis Kanevsky, Naveen Surendran, Kathleen McElwee, Lanyu Lei, Wendy Watson, Michael Pride, Ingrid Scully, Hatice Karauzum, Annaliesa Anderson & Mariano Young. (2023) Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age. Vaccine 41:45, pages 6625-6629.
Crossref
Crossref
Shuo Feng, Julie McLellan, Nicola Pidduck, Nia Roberts, Julian P.T. Higgins, Yoon Choi, Alane Izu, Mark Jit, Shabir A. Madhi, Kim Mulholland, Andrew J. Pollard, Beth Temple & Merryn Voysey. (2023) Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data. eClinicalMedicine 61, pages 102073.
Crossref
Crossref
Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, Juan Diego Velez, Per Ljungman, Johan Maertens, Dominik Selleslag, Kathleen M Mullane, Samir Nabhan, Qiuxu Chen, Ron Dagan, Peter Richmond, Caroline Daus, Kateasha Geddie, Gretchen Tamms, Tina Sterling, Shrita M Patel, Tulin Shekar, Luwy Musey & Ulrike K Buchwald. (2023) A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM). Clinical Infectious Diseases.
Crossref
Crossref
Federico Martinon-Torres, Jacek Wysocki, Leszek Szenborn, Alfonso Carmona-Martinez, Airi Poder, Ron Dagan, Peter Richmond, Christopher Gilbert, Marie-Chantale Trudel, Sheryl Flores, Robert Lupinacci, Richard McFetridge, Richard T. Wiedmann, Qiuxu Chen, Han Gerrits, Natalie Banniettis, Luwy Musey, Kara Bickham & Janusz Kaminski. (2023) A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1). Vaccine 41:21, pages 3387-3398.
Crossref
Crossref
Charles T. Quinn, Richard T. Wiedmann, Daniel Jarovsky, Eduardo Lopez-Medina, Hilze M. Rodriguez, Melanie Papa, Gordana Boggio, Qiong Shou, Ron Dagan, Peter Richmond, Kristen Feemster, Richard McFetridge, Gretchen Tamms, Robert Lupinacci, Luwy Musey & Kara Bickham. (2023) Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study. Blood Advances 7:3, pages 414-421.
Crossref
Crossref
Rajendra Rohokale & Zhongwu Guo. (2023) Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines. ACS Infectious Diseases 9:2, pages 178-212.
Crossref
Crossref
Robert Lupinacci, Richard Rupp, Orasri Wittawatmongkol, Jake Jones, Jeffrey Quinones, Betul Ulukol, Ron Dagan, Peter Richmond, Jon E. Stek, Lizbeth Romero, Sandra Koseoglu, Gretchen Tamms, Richard McFetridge, Jianing Li, Kyeongmi Cheon, Luwy Musey, Natalie Banniettis & Kara Bickham. (2023) A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED). Vaccine 41:5, pages 1142-1152.
Crossref
Crossref
Androniki Bili, Scott Dobson, Jeffrey Quinones, Wanatpreeya Phongsamart, Peninnah Oberdorfer, Pope Kosalaraksa, Ron Dagan, Peter Richmond, Marissa Wilck, Waldimir Vallejos, Christine Nunn, Richard McFetridge, Gretchen Tamms, Rong Fu, Robert Lupinacci, Luwy Musey, Natalie Banniettis & Kara Bickham. (2023) A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION). Vaccine 41:3, pages 657-665.
Crossref
Crossref
Chiang-Yun Chen, Kuo-Shiang Liao & Chung-Yi Wu. 2023. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology
422
436
.
Sachin S. Shivatare, Vidya S. Shivatare & Chi-Huey Wong. (2022) Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments. Chemical Reviews 122:20, pages 15603-15671.
Crossref
Crossref
Natalie Banniettis, Jacek Wysocki, Leszek Szenborn, Wanatpreeya Phongsamart, Punnee Pitisuttithum, Mika Rämet, Peter Richmond, Yaru Shi, Ron Dagan, Lori Good, Melanie Papa, Robert Lupinacci, Richard McFetridge, Gretchen Tamms, Clay Churchill, Luwy Musey & Kara Bickham. (2022) A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN). Vaccine 40:44, pages 6315-6325.
Crossref
Crossref
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca L. Sheets & Jorge Flores. (2022) Controlled Human Infection Models To Accelerate Vaccine Development. Clinical Microbiology Reviews 35:3.
Crossref
Crossref
Elisa Barbieri, Gloria Porcu, Tianyan Hu, Tanaz Petigara, Francesca Senese, Gian Marco Prandi, Antonio Scamarcia, Luigi Cantarutti, Anna Cantarutti & Carlo Giaquinto. (2022) A Retrospective Analysis to Estimate the Burden of Invasive Pneumococcal Disease and Non-Invasive Pneumonia in Children <15 Years of Age in the Veneto Region, Italy. Children 9:5, pages 657.
Crossref
Crossref
Shalom Ben-Shimol, Gili Regev-Yochay, Noga Givon-Lavi, Bart Adriaan van der Beek, Tal Brosh-Nissimov, Avi Peretz, Orli Megged, Ron Dagan, Ron Dagan, Jacob Amir, Galia Barkai, Diana Averbuch, Shraga Aviner, Ahuva Bachinski, Maskit Bar-Meir, Avihu Bar-Yochai, Ilana Benedikt, Rita Bernstein, Tal Brosh-Nissimov, Nael Elias, Dan Engelhard, Moshe Ephros, Daniel Glikman, Giora Gottesman, Galia Grisaru-Soen, Alex Guri, Imad Kasis, Nathan Keller, Zina Korenman, Amir Asher Kuperman, Orli Megged, Dan Miron, Meirav Mor, Hana Ofir-Mintzer, Avi Peretz, Uri Rubinstein, Yechiel Schlesinger, David Schwartz, Itamar Shalit, Eli Somekh, Isaac Srugo, Alvira Zbriger, Miriam Zucker, Gili Regev-Yochay, Marc Assous, Haim Ben-Zvi, Jihad Bishara, Rita Bardenstein, Larissa Brik, Bibiana Chazan, Michal Chowers, Ronit Cohen-Poradosu, Talia Finn, Alicia Embon, Sarit Freimann, Yuval Geffen, Danny Glikman, Mirit Hershman, Valery Istomin, Michal Katzir, Yoram Kennes, Shirley Khakshoor, Camellia Khoury-Assi, Mandelbaum Sari, Yasmin Maor, Danny Miron, Ilana Oren, Yosi Paitan, Yael Paran, Avi Peretz, Israel Potasman, Galia Rahav, Hagai Rechnitzer, Klaris Reisenberg, Shifra Sela, David Schwartz, Orna Schwartz, Pninit Shaked-Mishan, Yehudit Sheindler, Gill Smollan, Itzhak Srugo, Michal Stein, Jacob Strahilevitz, Olga Sverdlob, Violetta Temper, Yonit Viener-Well, Gabriel Weber, Miriam Weinberger, Oren Zimchony & Yevgenia Ztibba. (2022) Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance. Clinical Infectious Diseases 74:9, pages 1639-1649.
Crossref
Crossref
Elisa Barbieri, Gloria Porcu, Tianyan Hu, Tanaz Petigara, Francesca Senese, Gian Marco Prandi, Antonio Scamarcia, Luigi Cantarutti, Anna Cantarutti & Carlo Giaquinto. (2022) A Retrospective Database Analysis to Estimate the Burden of Acute Otitis Media in Children Aged <15 Years in the Veneto Region (Italy). Children 9:3, pages 436.
Crossref
Crossref
Laura L Hammitt, Dean Quinn, Ewa Janczewska, Francisco J Pasquel, Richard Tytus, K Rajender Reddy, Katia Abarca, Ilsiyar M Khaertynova, Ron Dagan, Jennifer McCauley, Kyeongmi Cheon, Alison Pedley, Tina Sterling, Gretchen Tamms, Luwy Musey & Ulrike K Buchwald. (2022) Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY). Open Forum Infectious Diseases 9:3.
Crossref
Crossref
Paulina Kaplonek, Ling Yao, Katrin Reppe, Franziska Voß, Thomas Kohler, Friederike Ebner, Alexander Schäfer, Ulrike Blohm, Patricia Priegue, Maria Bräutigam, Claney L. Pereira, Sharavathi G. Parameswarappa, Madhu Emmadi, Petra Ménová, Martin Witzenrath, Sven Hammerschmidt, Susanne Hartmann, Leif E. Sander & Peter H. Seeberger. (2022) A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae. Vaccine 40:7, pages 1038-1046.
Crossref
Crossref
Jakub K. Simon, Nina Breinholt Staerke, Maria Hemming-Harlo, Stacey Layle, Ron Dagan, Tulin Shekar, Alison Pedley, Patricia Jumes, Gretchen Tamms, Tina Sterling, Luwy Musey & Ulrike K. Buchwald. (2022) Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE). Vaccine 40:9, pages 1342-1351.
Crossref
Crossref
Annelies Müller, Jackie Kleynhans, Linda de Gouveia, Susan Meiring, Cheryl Cohen, Lucy Jane HathawayAnne von Gottberg. (2022)
Streptococcus pneumoniae
Serotypes Associated with Death, South Africa, 2012–2018
. Emerging Infectious Diseases 28:1, pages 166-179.
Crossref
Crossref
Eleni Koufoglou, Georgia Kourlaba & Athanasios Michos. (2021) Effect of prophylactic administration of antipyretics on the immune response to pneumococcal conjugate vaccines in children: a systematic review. Pneumonia 13:1.
Crossref
Crossref
Giuliana S. Oliveira, Maria Leonor S. Oliveira, Eliane N. Miyaji & Tasson C. Rodrigues. (2021) Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies. Vaccines 9:11, pages 1338.
Crossref
Crossref
Joon-Young Song, Chih-Jen Chang, Charles Andrews, Javier Diez-Domingo, Myoung-don Oh, Ron Dagan, Jonathan Hartzel, Alison Pedley, Jianing Li, Tina Sterling, Gretchen Tamms, Joseph A. Chiarappa, Jeannine Lutkiewicz, Luwy Musey, Yingmei Tu & Ulrike K. Buchwald. (2021) Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH). Vaccine 39:43, pages 6422-6436.
Crossref
Crossref
R.K. Lucinde, G. Ong'ayo, C. Houlihan, C. Bottomley, D Goldblatt, J.A.G. Scott & K.E. Gallagher. (2021) Pneumococcal conjugate vaccine dose-ranging studies in humans: A systematic review. Vaccine 39:36, pages 5095-5105.
Crossref
Crossref
Greiciely O. André, Mayara T. Borges, Lucas Assoni, Lucio F.C. Ferraz, Piplani Sakshi, Penelope Adamson, David L. Gordon, Abiodun D. Ogunniyi, Henrietta Venter, Thiago R. Converso & Michelle Darrieux. (2021) Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis. Vaccine 39:27, pages 3626-3632.
Crossref
Crossref
Zahin Amin-Chowdhury, Natalie Groves, Carmen L. Sheppard, David Litt, Norman K. Fry, Nick Andrews & Shamez N. Ladhani. (2021) Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes. Vaccine 39:14, pages 1997-2004.
Crossref
Crossref
Javed & Pintu Kumar Mandal. (2021) Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccines. Carbohydrate Research 502, pages 108277.
Crossref
Crossref
Ann Thanawastien, Kelsey E. Joyce, Robert T. Cartee, Laurel A. Haines, Stephen I. Pelton, Rodney K. Tweten & Kevin P. Killeen. (2021) Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid. Vaccine 39:11, pages 1652-1660.
Crossref
Crossref
Raymond S. W. Tsang. (2021) A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents: Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae and Streptococcus agalactiae. Microorganisms 9:2, pages 449.
Crossref
Crossref
Shalom Ben-Shimol, Noga Givon-Lavi, Leore Kotler, Bart Adriaan van der Beek, David Greenberg & Ron Dagan. (2021) Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines. Emerging Infectious Diseases 27:1, pages 150-160.
Crossref
Crossref
Ron Dagan & Shalom Ben-Shimol. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
223
247
.
Brenda Anna Kwambana-Adams, E. Kim Mulholland & Catherine Satzke. (2020) State-of-the-art in the pneumococcal field: Proceedings of the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11). Pneumonia 12:1.
Crossref
Crossref
Ravinder Mettu, Chiang-Yun Chen & Chung-Yi Wu. (2020) Synthetic carbohydrate-based vaccines: challenges and opportunities. Journal of Biomedical Science 27:1.
Crossref
Crossref
Heather L. Platt, David Greenberg, Bruce Tapiero, Robert A. Clifford, Nicola P. Klein, David C. Hurley, Tulin Shekar, Jianing Li, Kim Hurtado, Shu-Chih Su, Katrina M. Nolan, Camilo J. Acosta, Richard D. McFetridge, Kara Bickham & Luwy K. Musey. (2020) A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants. Pediatric Infectious Disease Journal 39:8, pages 763-770.
Crossref
Crossref
Katrina M Nolan, Marie E Bonhomme, Christina J Schier, Tina Green, Joseph M Antonello & Rocio D Murphy. (2020) Optimization and validation of a microcolony multiplexed opsonophagocytic killing assay for 15 pneumococcal serotypes. Bioanalysis 12:14, pages 1003-1020.
Crossref
Crossref
María A. Campanero-Rhodes, Alicia Lacoma, Cristina Prat, Ernesto García & Dolores Solís. (2020)
Development and Evaluation of a Microarray Platform for Detection of Serum Antibodies Against
Streptococcus pneumoniae
Capsular Polysaccharides
. Analytical Chemistry 92:11, pages 7437-7443.
Crossref
Crossref
Guillermo Ludwig, Selene Garcia-Garcia, Miguel Lanaspa, Pilar Ciruela, Cristina Esteva, Mariona Fernandez de Sevilla, Alvaro Diaz-Conradi, Carmina Marti, Montse Motje, Carme Galles, Montse Morta, Conchita Izquierdo, Fernando Moraga-Llop, Magda Campins, Luis Salleras, Mireia Jane, Angela Dominguez, Juan Jose Garcia-Garcia & Carmen Muñoz-Almagro. (2020) Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain. PLOS ONE 15:2, pages e0228612.
Crossref
Crossref
Jinfu Xie, Yuhua Zhang, Ivette Caro-Aguilar, Lani Indrawati, William J. Smith, Cecilia Giovarelli, Michael A. Winters, John MacNair, Jian He, Chitrananda Abeygunawardana, Luwy Musey, Michael Kosinski & Julie M. Skinner. (2020) Immunogenicity Comparison of a Next Generation Pneumococcal Conjugate Vaccine in Animal Models and Human Infants. Pediatric Infectious Disease Journal 39:1, pages 70-77.
Crossref
Crossref
Catherine G. Sutcliffe, Anita Shet, Rosemol Varghese, Balaji Veeraraghavan, Anand Manoharan, Brian Wahl, Sara Chandy, Jack Sternal, Raziuddin Khan, Rakesh Kumar Singh, Mathuram Santosham & Narendra K. Arora. (2019) Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study. BMC Infectious Diseases 19:1.
Crossref
Crossref